genOway Germany GmbH

The development of a new drug costs roughly 800 M.USD. This huge investment has to cover both the development of the drug itself and the cost of unfruitful work. Dead-ends can represent up to 80% of the total cost of a successful drug. Major challenges in the drug development process are (1) to reduce high failure rates due to faulty candidate selection and false positives and (2) to identify all the potential candidates among the false negatives. There are thus great potential savings to be realized by making development more efficient. To help make these savings, genOway designs, develops and markets technologies and proprietary innovative genetically modified biological models. These solutions aim to increase the predictability and throughput of research in target validation, drug screening and pharmacological - toxicological studies.

Contact Details: Grundstrasse 16 Hamburg 20257 Germany Tel: 49 (0) 40 40 19 71 00 Fax: 49 (0) 40 43 20 82 61 Email: info@genoway.com. WWW: www.genoway.com/

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 272 times since April 2007, the link to the organisation's website has been followed 49 times

Search for more companies in Hamburg

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for genOway Germany GmbH